Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

The BiOSS stent.

Gil RJ, Bil J, Vassilev D.

EuroIntervention. 2015 May 19;11 Suppl V:V153-V154. doi: 10.4244/EIJV11SVA37. No abstract available.

2.

Regular Drug-Eluting Stent vs Dedicated Coronary Bifurcation BiOSS Expert Stent: Multicenter Open-Label Randomized Controlled POLBOS I Trial.

Gil RJ, Bil J, Džavík V, Vassilev D, Kern A, Formuszewicz R, Zalewska-Adamiec M, Dobrzycki S.

Can J Cardiol. 2015 May;31(5):671-8. doi: 10.1016/j.cjca.2014.12.024. Epub 2014 Dec 24.

PMID:
25828372
3.

Temporal trends and patterns in percutaneous treatment of coronary artery disease in Poland in the years 2005-2011.

Siudak Z, Ochała A, Lesiak M, Witkowski A, Gil RJ, Legutko J, Maciejewski P, Fijorek K, Dudek D.

Kardiol Pol. 2015 Mar 3. doi: 10.5603/KP.a2015.0037. [Epub ahead of print]

4.

Changes in desmin expression in patients with cardiac diastolic dysfunction and preserved or reduced ejection fraction.

Pawlak A, Gil RJ, Nasierowska-Guttmejer AM, Kasprzak JD.

Adv Med Sci. 2015 Mar;60(1):148-55. doi: 10.1016/j.advms.2015.01.009. Epub 2015 Feb 11.

PMID:
25732530
5.

First-in-man study of dedicated bifurcation sirolimus-eluting stent: 12-month results of BiOSS LIM® Registry.

Gil RJ, Bil J, Vassiliev D, Iñigo Garcia LA.

J Interv Cardiol. 2015 Feb;28(1):51-60. doi: 10.1111/joic.12180.

PMID:
25689548
6.

Double bifurcation optimization stent system technique for left main stenosis.

Vassilev D, Mateev H, Alexandrov A, Karamfiloff K, Gil RJ.

J Interv Cardiol. 2014 Dec;27(6):570-3. doi: 10.1111/joic.12155. Epub 2014 Sep 16.

PMID:
25224296
7.

Use of bioresorbable vascular scaffolds in patients with stable angina and acute coronary syndromes. Polish National Registry.

Rzeszutko Ł, Siudak Z, Włodarczak A, Lekston A, Depukat R, Ochała A, Gil RJ, Balak W, Marć M, Kochman J, Zasada W, Dudek D.

Kardiol Pol. 2014;72(12):1394-9. doi: 10.5603/KP.a2014.0147. Epub 2014 Jul 8.

PMID:
25001567
8.

Transcatheter aortic valve implantation complicated by acute pericardial tamponade.

Możeńska O, Suwalski P, Pawlak A, Kulawik T, Byczkowska K, Gil RJ.

Postepy Kardiol Interwencyjnej. 2014;10(1):26-8. doi: 10.5114/pwki.2014.41463. Epub 2014 Mar 23.

9.

Dedicated bifurcation paclitaxel-eluting stent BiOSS Expert® in the treatment of distal left main stem stenosis.

Bil J, Gil RJ, Vassilev D, Rzezak J, Kulawik T, Pawlowski T.

J Interv Cardiol. 2014 Jun;27(3):242-51. doi: 10.1111/joic.12119. Epub 2014 Apr 7.

PMID:
24708143
10.

[Cardiological manifestation of MELAS syndrome associated with mutation at position 3234].

Pawlak A, Pronicki M, Iwanicka-Pronicka K, Kuśnierz J, Płoski R, Pollak A, Gil RJ.

Kardiol Pol. 2014;72(1):83. doi: 10.5603/KP.2014.0009. Polish. No abstract available.

11.

[Guidelines of the Association of Cardiovascular Interventions of the Polish Cardiac Society for certification of coronary diagnosts and percutaneous coronary intervention operators and invasive cardiology centers in Poland].

Dudek D, Legutko J, Ochała A, Gil RJ, Araszkiewicz A, Lesiak M, Deptuch T, Karcz M, Peruga Z, Szkutnik M, Wojakowski W, Witkowski A, Opolski G, Stępińska J; Association of Cardiovascular Interventions of the Polish Cardiac Society.

Kardiol Pol. 2013;71(12):1332-6. doi: 10.5603/KP.2013.0344. Polish. No abstract available.

12.

Stenting below-the-knee bifurcations with dedicated bifurcation stent BiOSS Lim - first in man case report.

Vassilev D, Mateev H, Alexandrov A, Stankev M, Rigatelli G, Gil RJ.

Cardiovasc Revasc Med. 2014 Apr;15(3):171-7. doi: 10.1016/j.carrev.2013.09.005. Epub 2013 Oct 22.

PMID:
24157310
13.

Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.

Maggioni AP, Anker SD, Dahlström U, Filippatos G, Ponikowski P, Zannad F, Amir O, Chioncel O, Leiro MC, Drozdz J, Erglis A, Fazlibegovic E, Fonseca C, Fruhwald F, Gatzov P, Goncalvesova E, Hassanein M, Hradec J, Kavoliuniene A, Lainscak M, Logeart D, Merkely B, Metra M, Persson H, Seferovic P, Temizhan A, Tousoulis D, Tavazzi L; Heart Failure Association of the ESC.

Eur J Heart Fail. 2013 Oct;15(10):1173-84. doi: 10.1093/eurjhf/hft134. Epub 2013 Aug 26.

14.
15.

[Comment on the letter regarding "Arrhythmogenic right ventricular cardiomyopathy in a patient with anomalous coronary arteries and ventricular tachycardia induced by physical effort].

Pawlak A, Gil RJ, Biernacka EK, Czarnowska E.

Kardiol Pol. 2013;71(2):214. doi: 10.5603/KP.2013.0026. Polish. No abstract available.

16.

[The regulatory mechanisms of protein expression in heart failure patients' cardiomyocytes. The ubiquitin-proteasome system. Autophagy].

Pawlak A, Bil J, Gil RJ.

Kardiol Pol. 2012;70(11):1170-6. Review. Polish. No abstract available.

17.

Significance of low desmin expression in cardiomyocytes in patients with idiopathic dilated cardiomyopathy.

Pawlak A, Gil RJ, Grajkowska W, Nasierowska-Guttmejer AM, Rzezak J, Kulawik T.

Am J Cardiol. 2013 Feb 1;111(3):393-9. doi: 10.1016/j.amjcard.2012.09.036. Epub 2012 Nov 22.

PMID:
23178054
18.

Importance of bifurcation angle in bifurcation stenting.

Vassilev D, Alexandrov A, Le D, Nguyen K, Nguyen J, Phan H, Gil RJ.

Chin Med J (Engl). 2012 Nov;125(22):4122-5. No abstract available.

PMID:
23158154
19.

[Heart failure in female patient in peripartum period - how to determine the aetiology?].

Gil K, Drożdż J, Pawlak A, Michałek A, Byczkowska K, Koniarek W, Gil RJ.

Kardiol Pol. 2012;70(10):1043-5. Polish.

20.

The determinants of side branch compromise after main vessel stenting in coronary bifurcation lesions.

Vassilev D, Gil RJ, Koo BK, Gibson CM, Nguyen T, Hoang T, Gotcheva N.

Kardiol Pol. 2012;70(10):989-97.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk